Brief: Avenue Therapeutics Inc- As Of September 30, 2022, Avenue's Cash And Cash Equivalents Totaled $0.2 Million
Nov 10 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS INC- AS OF SEPTEMBER 30, 2022,
AVENUE'S CASH
AND CASH EQUIVALENTS TOTALED $0.2 MILLION
* AVENUE THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.45 PER
SHARE
Source text for Eikon: ID:nGNX5M4yr7
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary